COLLAGENASE IN SJOGRENS-SYNDROME

KONTTINEN YT, KANGASPUNTA P, LINDY O, TAKAGI M, SORSA T, SEGERBERG M, Tschesche H, EISEN AZ (1994)
ANNALS OF THE RHEUMATIC DISEASES 53(12): 836-839.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
DOI
Autor*in
KONTTINEN, YT; KANGASPUNTA, P; LINDY, O; TAKAGI, M; SORSA, T; SEGERBERG, M; Tschesche, HaraldUniBi; EISEN, AZ
Einrichtung
Fakultät für Chemie > Biochemie I
Abstract / Bemerkung
Objective-To study collagenase production in labial salivary glands in patients with Sjogren's syndrome (SS). Methods-Collagenases were localised in labial salivary glands by immunohistochemistry. Collagenase activity against triple helical type I collagen monomers in stimulated saliva was measured using sodium dodecyl sulphate polyacrylamide gel electrophoresis and laser densitometry; tissue inhibitor metalloproteinase (TIMP) was measured by enzyme Linked immunosorbent assay. Results-Cells containing collagenase of matrix metalloproteinase (MMP)-1 type were more frequent and more intensely staining in SS than in healthy glands. Only SS saliva contained functional enzyme (11.7 (6.8) x 10(-6) IU/1). Cells containing MMP-8 type neutrophil collagenase were not found in situ, which was in accordance with sialochemical findings/doxycycline inhibition studies. TIMP was found in both SS and normal saliva. Conclusions-Fibroblast, but not neutrophil type, collagenase is synthesised, secreted, and subsequently activated, but is not inhibited by TIMP in labial salivary glands or saliva in SS. Collagenase may destroy glandular and salivary duct tissue and perturb factors influencing the morphogenetic extracellular matrix.
Erscheinungsjahr
1994
Zeitschriftentitel
ANNALS OF THE RHEUMATIC DISEASES
Band
53
Ausgabe
12
Seite(n)
836-839
ISSN
0003-4967
Page URI
https://pub.uni-bielefeld.de/record/1641996

Zitieren

KONTTINEN YT, KANGASPUNTA P, LINDY O, et al. COLLAGENASE IN SJOGRENS-SYNDROME. ANNALS OF THE RHEUMATIC DISEASES. 1994;53(12):836-839.
KONTTINEN, Y. T., KANGASPUNTA, P., LINDY, O., TAKAGI, M., SORSA, T., SEGERBERG, M., Tschesche, H., et al. (1994). COLLAGENASE IN SJOGRENS-SYNDROME. ANNALS OF THE RHEUMATIC DISEASES, 53(12), 836-839. https://doi.org/10.1136/ard.53.12.836
KONTTINEN, YT, KANGASPUNTA, P, LINDY, O, TAKAGI, M, SORSA, T, SEGERBERG, M, Tschesche, Harald, and EISEN, AZ. 1994. “COLLAGENASE IN SJOGRENS-SYNDROME”. ANNALS OF THE RHEUMATIC DISEASES 53 (12): 836-839.
KONTTINEN, Y. T., KANGASPUNTA, P., LINDY, O., TAKAGI, M., SORSA, T., SEGERBERG, M., Tschesche, H., and EISEN, A. Z. (1994). COLLAGENASE IN SJOGRENS-SYNDROME. ANNALS OF THE RHEUMATIC DISEASES 53, 836-839.
KONTTINEN, Y.T., et al., 1994. COLLAGENASE IN SJOGRENS-SYNDROME. ANNALS OF THE RHEUMATIC DISEASES, 53(12), p 836-839.
Y.T. KONTTINEN, et al., “COLLAGENASE IN SJOGRENS-SYNDROME”, ANNALS OF THE RHEUMATIC DISEASES, vol. 53, 1994, pp. 836-839.
KONTTINEN, Y.T., KANGASPUNTA, P., LINDY, O., TAKAGI, M., SORSA, T., SEGERBERG, M., Tschesche, H., EISEN, A.Z.: COLLAGENASE IN SJOGRENS-SYNDROME. ANNALS OF THE RHEUMATIC DISEASES. 53, 836-839 (1994).
KONTTINEN, YT, KANGASPUNTA, P, LINDY, O, TAKAGI, M, SORSA, T, SEGERBERG, M, Tschesche, Harald, and EISEN, AZ. “COLLAGENASE IN SJOGRENS-SYNDROME”. ANNALS OF THE RHEUMATIC DISEASES 53.12 (1994): 836-839.

22 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Acrolein toxicity at advanced age: present and future.
Igarashi K, Uemura T, Kashiwagi K., Amino Acids 50(2), 2018
PMID: 29249019
Activation of MMP-9 activity by acrolein in saliva from patients with primary Sjögren's syndrome and its mechanism.
Uemura T, Suzuki T, Saiki R, Dohmae N, Ito S, Takahashi H, Toida T, Kashiwagi K, Igarashi K., Int J Biochem Cell Biol 88(), 2017
PMID: 28483671
Increase in acrolein-conjugated immunoglobulins in saliva from patients with primary Sjögren's syndrome.
Hirose T, Saiki R, Uemura T, Suzuki T, Dohmae N, Ito S, Takahashi H, Ishii I, Toida T, Kashiwagi K, Igarashi K., Clin Chim Acta 450(), 2015
PMID: 26301996
Targeting TNF-α suppresses the production of MMP-9 in human salivary gland cells.
Aota K, Azuma M., Arch Oral Biol 58(12), 2013
PMID: 24200302
Saliva and dental erosion.
Buzalaf MA, Hannas AR, Kato MT., J Appl Oral Sci 20(5), 2012
PMID: 23138733
Intense correlation between protein-conjugated acrolein and primary Sjögren's syndrome.
Higashi K, Yoshida M, Igarashi A, Ito K, Wada Y, Murakami S, Kobayashi D, Nakano M, Sohda M, Nakajima T, Narita I, Toida T, Kashiwagi K, Igarashi K., Clin Chim Acta 411(5-6), 2010
PMID: 19968980
Proteome analysis of gelatin-bound salivary proteins in patients with primary Sjögren's syndrome: identification of matrix metalloproteinase-9.
Ito K, Funayama S, Hitomi Y, Nomura S, Katsura K, Saito M, Hayashi T, Kaneko N, Nohno K, Igarashi A., Clin Chim Acta 403(1-2), 2009
PMID: 19302990
Abnormal basement membrane type IV collagen alpha-chain composition in labial salivary glands in Sjögren's syndrome.
Poduval P, Sillat T, Virtanen I, Porola P, Konttinen YT., Arthritis Rheum 60(4), 2009
PMID: 19333954
Pathophysiology of Sjögren's syndrome.
García-Carrasco M, Fuentes-Alexandro S, Escárcega RO, Salgado G, Riebeling C, Cervera R., Arch Med Res 37(8), 2006
PMID: 17045106
Increase in the ratio of matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 in saliva from patients with primary Sjögren's syndrome.
Asatsuma M, Ito S, Watanabe M, Takeishi H, Nomura S, Wada Y, Nakano M, Gejyo F, Igarashi A., Clin Chim Acta 345(1-2), 2004
PMID: 15193983
Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: an update.
Cha S, Peck AB, Humphreys-Beher MG., Crit Rev Oral Biol Med 13(1), 2002
PMID: 12097234
Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
Cha S, Nagashima H, Brown VB, Peck AB, Humphreys-Beher MG., Arthritis Rheum 46(5), 2002
PMID: 12115247
Suppression of tumor necrosis factor alpha-induced matrix metalloproteinase 9 production in human salivary gland acinar cells by cepharanthine occurs via down-regulation of nuclear factor kappaB: a possible therapeutic agent for preventing the destruction of the acinar structure in the salivary glands of Sjögren's syndrome patients.
Azuma M, Aota K, Tamatani T, Motegi K, Yamashita T, Ashida Y, Hayashi Y, Sato M., Arthritis Rheum 46(6), 2002
PMID: 12115190
Evaluation of collagenase activity, matrix metalloproteinase-8, and matrix metalloproteinase-13 in horses with chronic obstructive pulmonary disease.
Raulo SM, Sorsa TA, Kiili MT, Maisi PS., Am J Vet Res 62(7), 2001
PMID: 11453493
Suppression of tumor necrosis factor alpha-induced matrix metalloproteinase 9 production by the introduction of a super-repressor form of inhibitor of nuclear factor kappaBalpha complementary DNA into immortalized human salivary gland acinar cells. Prevention of the destruction of the acinar structure in Sjögren's syndrome salivary glands.
Azuma M, Aota K, Tamatani T, Motegi K, Yamashita T, Harada K, Hayashi Y, Sato M., Arthritis Rheum 43(8), 2000
PMID: 10943866
Sjögren's syndrome.
Fox RI, Michelson P, Casiano CA, Hayashi J, Stern M., Clin Dermatol 18(5), 2000
PMID: 11134854
Prolactin up-regulates cathepsin B and D expression in minor salivary glands of patients with Sjögren's syndrome.
Steinfeld S, Maho A, Chaboteaux C, Daelemans P, Pochet R, Appelboom T, Kiss R., Lab Invest 80(11), 2000
PMID: 11092531
72-kDa and 92-kDa gelatinases in saliva of patients with human immunodeficiency virus infection.
Mellanen L, Salo T, Ingman T, Konttinen YT, Lähdevirta J, Sorsa T., Acta Odontol Scand 56(3), 1998
PMID: 9688221
Standardized assessment of disease status in patients with primary Sjögren's syndrome: the foundation for creating criteria for disease activity and damage?
Oxholm P, Asmussen K., Med Hypotheses 50(6), 1998
PMID: 9710321
The activation and function of host matrix metalloproteinases in dentin matrix breakdown in caries lesions.
Tjäderhane L, Larjava H, Sorsa T, Uitto VJ, Larmas M, Salo T., J Dent Res 77(8), 1998
PMID: 9719036
Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren's syndrome.
Konttinen YT, Halinen S, Hanemaaijer R, Sorsa T, Hietanen J, Ceponis A, Xu JW, Manthorpe R, Whittington J, Larsson A, Salo T, Kjeldsen L, Stenman UH, Eisen AZ., Matrix Biol 17(5), 1998
PMID: 9822200
A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: saliva from patients with Sjögren's syndrome contain increased latent and active gelatinase-B levels.
Hanemaaijer R, Visser H, Konttinen YT, Koolwijk P, Verheijen JH., Matrix Biol 17(8-9), 1998
PMID: 9923658

10 References

Daten bereitgestellt von Europe PubMed Central.

The Copenhagen criteria for Sjogren's syndrome.
Manthorpe R, Oxholm P, Prause JU, Schiodt M., Scand. J. Rheumatol. Suppl. 61(), 1986
PMID: 3473631
Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein.
Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA, Eisen AZ., J. Biol. Chem. 261(14), 1986
PMID: 3009463
Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases.
Hasty KA, Pourmotabbed TF, Goldberg GI, Thompson JP, Spinella DG, Stevens RM, Mainardi CL., J. Biol. Chem. 265(20), 1990
PMID: 2164002
Matrix metalloproteinases and their inhibitors in connective tissue remodeling.
Woessner JF Jr., FASEB J. 5(8), 1991
PMID: 1850705
Collagenase: effect on the morphogenesis of embryonic salivary epithelium in vitro.
Grobstein C, Cohen J., Science 150(3696), 1965
PMID: 5837103
Collagen involvement in branching morphogenesis of embryonic lung and salivary gland.
Spooner BS, Faubion JM., Dev. Biol. 77(1), 1980
PMID: 7190523
Human neutrophil collagenase cleaves alpha 1-antitrypsin.
Michaelis J, Vissers MC, Winterbourn CC., Biochem. J. 270(3), 1990
PMID: 2173552
Human leukocyte collagenase: characterization of enzyme kinetics by a new method.
Turto H, Lindy S, Uitto VJ, Wegelius O, Uitto J., Anal. Biochem. 83(2), 1977
PMID: 203207
Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential.
Suomalainen K, Sorsa T, Golub LM, Ramamurthy N, Lee HM, Uitto VJ, Saari H, Konttinen YT., Antimicrob. Agents Chemother. 36(1), 1992
PMID: 1317148
Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation.
Springman EB, Angleton EL, Birkedal-Hansen H, Van Wart HE., Proc. Natl. Acad. Sci. U.S.A. 87(1), 1990
PMID: 2153297
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 7864694
PubMed | Europe PMC

Suchen in

Google Scholar